Skip to main content

867 publications

Name Date Type Actions

Strong growth in Revenues in the 3rd quarter

Vétoquinol recorded strong growth in the 3rd quarter of 2009, despite an unfavourable exchange rate effect. The strength in sales was due to a combination of the contribution of acquisitions in Italy and India and sustained organic growth.

14/10/2009 Public releases

Strong Results in the first half of 2010

The Board of Directors of Vétoquinol, meeting on August 30, reviewed the group’s business and approved its interim 2010 financial statements.

30/08/2010 Public releases

Strong Revenue growth in the first quarter of 2012

Vétoquinol achieved Q1 2012 sales of €77.0 million, up 15.9% compared to Q1 2011.

20/04/2012 Public releases

Strong Sales in the 3rd Quarter of 2010

Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments.

19/10/2010 Public releases

Sustainable development, an integral part of Vetoquinol

Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet".

13/09/2023 Press releases communication

Sustained revenue growth in 2006

15/02/2007 Public releases

The reference products demonstrate solid growth

Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013.

29/08/2013 Public releases

Third quarter revenues: €132 million

14/10/2021 Public releases

Universal registration document 2021

Universal Registration Document including the Annual Financial Report

05/05/2022 Reference document

Universal registration document 2022

Universal Registration Document including the Annual Financial Report

05/05/2023 Reference document